New here but would appreciate Dr Kss and anyone’s else feedback on a tiny biotech I have a small stake in. Ticker on otc is biad. They stopped reporting to sec due to fact they are operating on shoe string budget. They have 44 million shares and share structure has remained same for many years. They have 3 devices in development but only one that matters imo is Mids device. http://midsmed.com. They partnered w zenosense ticker Zeno to finish funding project. Biad owns 60% Zeno 40%. Zeno appears to have an angel investor who continues to fund project. Mids is poc blood test that supposedly could be used for a host of tests. They are first trying it as a poc test for a specific bio marker to confirm a heart attack. Soc test normally takes hours to confirm and this supposedly can do it in minutes. You can see old biad prs on their website bioamd.com and Zeno has been doing prs for last 8 months including patent received in June. Device if it worked reminds me of theranos claims b4 they were proved to be a hoax. Obviously high risk besides biad being a very illiquid stock.
Love to hear any thoughts on biad.
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.